Sponsor study identifier
interventional
38
1 country
1
Study Start
August 29, 2022
Actual (reported)Primary Completion
September 6, 2022
Actual (reported)Study Completion
September 14, 2022
Actual (reported)This is an open-label, single-arm, single-centre, proof-of-concept, safety and efficacy, clinical study of SkinQ Glow Bright Wonder Mask in Healthy Human Subjects and adequate representation of varied skin types \[Normal, Oily, Dry, Combined and Sensitive skin\]. The rationale of the study is to evaluate whether the product SkinQ Glow Bright Wonder Mask is providing an instant skin tanning reduction in 15 mins, smoother, softer and glows skin, and even/brighter complexion in 15 mins, instant improvement in skin brightness and not just a marketing gimmick. It is also to assess the efficacy of the product in its performance for the following parameters:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 14, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 3, 2022
Actual (reported)August 12, 2022
Actual (reported)August 29, 2022
Actual (reported)September 6, 2022
Actual (reported)September 14, 2022
Actual (reported)To assess the instant change in skin colour, and tone
To assess the instant change in skin colour, and tone with a single application of the test product using Skin ColorimeterCL-400 by measuring CIE (International Commission on Illumination) L-, a-, b- value, ITA (Individual Topology Angle)
On Day 01 before application and after product removal at 5 mins and 15 mins
Surface evaluation of the living skin SELS® (Surface Evaluation of the Living Skin)
To assess the instant change in skin surface i.e. smoothness, roughness, scaliness, wrinkles based on the grey levels of the image in a single application using Visioscan®VC20plus
On Day 01 before application and after product removal at 5 mins and 15 mins
To assess the instant change in skin pores
To assess the instant change in skin pores in a single application using Visioscan®VC20plus
from the baseline on Day 01 before application and after product removal at 5 mins and 15 mins
Instant change in skin brightness, skin tanning
on Day 01 before application and after product removal at 15 mins
Local Irritation (erythema, scaling, itching, and burning)
On Day 01 before application and after product removal at 15 mins
Skin Pigmentation
On Day 01 before application and after product removal at 15 mins
Sensorial Evaluations
Before product application and after 15 mins of post product removal
Treatment Emergent adverse events
On Day 01 after product application and removal
Mode of Usage: Cleanse and dry face. Apply 1 tsp or 5g of the product. Apply with clean finger or brush to full face. Leave to dry for 15 minutes. Wipe with wet cotton or rinse with cool water. Route of Administration: Topical
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
NovoBliss Research Pvt Ltd
Gandhinagar, Gujarat, India
Dr Nayan K Patel, MBBS
Medical Director
38 participants (actual enrollment reported by the registry).
First Submitted
August 3, 2022
First Posted
August 12, 2022
Study Start
August 29, 2022
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
September 6, 2022
Actual (reported)Study Completion
September 14, 2022
Actual (reported)Last Updated
September 29, 2022
Record last verified: 2022-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: